Bioworld Financial Watch articles from August 2003

Bioworld Financial Watch archives from August 2003

Biotech heavyweights challenge patent position held by Columbia.
August 4, 2003... Genzyme Corp., Biogen Inc. and Abbott Bioresearch Center filed suit earlier this summer against Columbia University in the U.S. District Court of Massachusetts, claiming that a new patent issued to the university in September 2002 that centered...

Public financing of biotechnology: July 2003.
August 4, 2003... Public Financing Of Biotechnology: July 2003 1. COMMENCED TRADING IN JULY Company Date Date Shares/ Price (Symbol) Filed Comm. Units (M) INITIAL OFFERINGS There were no...

Other financings of public biotechnology companies: July 2003.
August 4, 2003... Other Financings Of Public Biotechnology Companies: July 2003 TOTAL: $2,168.94M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: July 2003.
August 4, 2003... Venture Capital And Corporate Investments In Biotechnology Companies: July 2003 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $330.575M Company Location Date Amt. (M) Alnylam ...

BioWorld stock report for public biotechnology companies.
August 4, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 7/25 8/1 Aastrom Biosci ASTM 0.89 0.9 Abgenix ABGX 13.05 12.22...

Genzyme's buyout of SangStat: ripening treasure in polyclonals?
August 11, 2003... Last week's news of a planned $600 million cash buyout of SangStat Medical Corp. by Genzyme Corp. made headlines for its obvious virtues on both sides--but down the road an even bigger boon might be coming for the merged pair. It's a benefit...

Clinical trial update: July 2003.
August 11, 2003... Clinical Trial Update: July 2003 Company * Product Description (Country; Symbol) AUTOIMMUNE AtheroGenics AGIX-4207 Oral treatment; an intravenous Inc. (AGIX) compound...

Non-U.S. clinical trials, regulatory submissions recommendations and approvals: July 2003.
August 11, 2003... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: Company Product Description (Country; Symbol) AUTOIMMUNE Centocor Inc. Remicade Infliximab;...

FDA submissions, approvals and other actions: July 2003.
August 11, 2003... FDA Submissions, Approvals And Other Actions: July 2003 Company * Product Description (Country; Symbol) AUTOIMMUNE Amgen Inc. Enbrel Etanercept; tumor (AMGN) ...

BioWorld stock report for public biotechnology companies.
August 11, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 8/1 8/8 WK YTD (000) Aastrom Biosci ASTM ...

New interpretation of SBIR rules puts squeeze on VC-backed firms.
August 18, 2003... As a bridge over troubled financing waters, Small Business Innovation Research grants have an indisputable value, and the advantages are especially well known to start-up biotechnology companies that have availed them selves of SBIRs. But...

Biotechnology company deals with other biotechnology companies: collaborations, agreements, equity participation, June 19-August 13, 2003 (#).
August 18, 2003... Company * Company * Type/Product Area (Country; (Country; Symbol) Symbol) 4SC AG * Esteve SA Collaboration to identify (Germany) (Spain) drug...

Biotechnology company deals with miscellaneous companies: collaborations, agreements, equity participation, June 19-August 13, 2003 (#).
August 18, 2003... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, June 19-August 13, 2003 (#) Company * Company * Type/Product Area (Country; Symbol) Applied DNA Harriet &...

Manufacturing, marketing and distribution agreements between biotech companies: June 19-August 13, 2003 (#).
August 18, 2003... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: June 19-August 13, 2003 (#) Company * Company * Product (Country; (Country; Symbol) Symbol) Affymetrix...

Biotech--biotech collaborations: modified and terminated agreements, June 19-August 13, 2003 (#).
August 18, 2003... Biotech--Biotech Collaborations: Modified And Terminated Agreements, June 19-August 13, 2003 (#) I. MODIFIED AGREEMENTS Company * Company * Change from original (Country; (Country; agreement...

BioWorld stock report for public biotechnology companies.
August 18, 2003... Bioworld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 8/8 8/15 ...

Genentech, PDL dispute could mean lawsuit troubles ahead.
August 25, 2003... It wasn't exactly a "shot heard 'round the world," but Genentech Inc.'s balking earlier this month at paying full royalties to Protein Design Labs Inc. on the asthma drug Xolair may have been the opening salvo in a significant global war. ...

U.S. public offering performance by underwriter: Jan. 1-Aug. 20, 2003 *.
August 25, 2003... U.S. Public Offering Performance By Underwriter: Jan. 1-Aug. 20, 2003 (*) Underwriter Biotechnology Date Offering 8/20/03 Company Priced Price Per Share ...

BioWorld stock report for public biotechnology companies.
August 25, 2003... BioWorld Stock Report For Public Biotechnology Companies. % Change Company Symbol Close Close Vol 8/15 8/22 WK...